A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.
Where this comes from
- Record sourced from PubMed, PMID 29302357.
- Also identified by DOI 10.1038/s41536-017-0026-z and PMC identifier 5677945.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building.